Ascentage Pharma Group International American Depository Shares (AAPG) vs Alpha Tau Medical (DRTS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alpha Tau Medical (DRTS) has outperformed Ascentage Pharma Group International American Depository Shares (AAPG) over the past year, gaining 245.0% versus a loss of 61.6%. Ascentage Pharma Group International American Depository Shares is the larger company by market cap ($1.36 billion vs $1.29 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AAPG | DRTS |
|---|---|---|
| Share price | $14.55 | $14.00 |
| Market cap | $1.36B | $1.29B |
| 1-day change | -4.09% | -1.75% |
| YTD return | -43.06% | +187.88% |
| 1-year return | -61.57% | +245.04% |
| 5-year return | — | +44.08% |
| EPS (TTM) | $-2.26 | $-1.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $38.58 | $15.79 |
| 52-week low | $14.46 | $3.43 |
| Distance from 52-week high | -62.29% | -11.34% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +223.92% | +27.14% |
| Average volume | 6.33K | 566.95K |
| Shares outstanding | 93.39M | 92.48M |
| Employees | 828 | 121 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DRTS has outperformed AAPG by 306.6 percentage points over the past year.
About Ascentage Pharma Group International American Depository Shares
AAPG stock →Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation.
Health Care · Biotechnology: Pharmaceutical Preparations · 828 employees
About Alpha Tau Medical
DRTS stock →Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
Health Care · Medical/Dental Instruments · 121 employees
AAPG vs DRTS FAQ
Which is bigger, Ascentage Pharma Group International American Depository Shares or Alpha Tau Medical?
Ascentage Pharma Group International American Depository Shares (AAPG) is larger, with a market capitalization of $1.36B compared with $1.29B for Alpha Tau Medical (DRTS).
Which stock has performed better over the past year, AAPG or DRTS?
DRTS returned +245.04% over the past 12 months, compared with -61.57% for AAPG (price return, excluding dividends). Past performance does not predict future results.
Are Ascentage Pharma Group International American Depository Shares and Alpha Tau Medical in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Ascentage Pharma Group International American Depository Shares and Medical/Dental Instruments for Alpha Tau Medical.